Perbedaan Penta Valent Tbk. dan Organon Pharma Indonesia Tbk.: Penta Valent Tbk. diperdagangkan di Rp308 (kapitalisasi pasar 547,34 M, volume 24 jam 764,8 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Penta Valent Tbk. jauh lebih besar — sekitar 5,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PEVE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 547,34 M | 104,4 M |
Volume | 764,8 rb | — |
Lot | 7,65 rb | — |
Perputaran | 234,84 jt | — |
Harga Rata-rata | 307,07 | — |
Nilai Transaksi | 234,84 jt | — |
Harga Ekuilibrium Indikatif | 308 | — |
Volume Ekuilibrium Indikatif | 352 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Selengkapnya di halaman PEVE →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →